Bartronics India Limited signed an MoU with Huwel Lifesciences to invest ₹50 crore in tranches for a 15% equity stake. BIL gains board representation, Right of First Refusal (ROFR), Tag-Along rights, and a call option to acquire an extra 15% within 12 months. The partnership focuses on R&D, product launches, and market expansion, subject to due diligence and approvals.